Synaptophysin is a protein used as a marker of presynaptic terminals. We previously showed that, in dorsolateral striatum of the rat, 2 weeks' haloperidol treatment up-regulated synaptophysin mRNA. We have now investigated the effects of 16 weeks' treatment with haloperidol on synaptophysin expression in dorsolateral striatum, frontoparietal cortex and hippocampus, in order to see if the implied haloperidol-induced synaptic plasticity persists. For comparison, in both the 2-and 16-week treatment groups we determined the mRNA abundance of the neuronal plasticity-associated gene GAP-43, and the housekeeping gene cyclophilin. Sixteen weeks' haloperidol administration increased synaptophysin mRNA in striatum and frontoparietal cortex but not in hippocampus. The increase was demonstrable both regionally and per neuron. A similar trend was seen for synaptophysin protein using immunoautoradiography. GAP-43 mRNA was elevated in frontoparietal cortex by 2 weeks' haloperidol but was not significantly changed in any area in the 16-week treatment group. Cyclophilin mRNA, a marker of overall gene expression, was unaffected by haloperidol. The persistent increase in synaptophysin expression supports the evidence that chronic antipsychotic drug treatment induces synaptic reorganisation in some striatal and cortical neuron populations, whereas the GAP-43 mRNA data suggest that haloperidol does not produce a sustained alteration of neuronal plasticity. Further study of plasticity-associated gene expression may be valuable in clarifying the long-term neuronal and synaptic changes produced by antipsychotics, and how these are related to the neurochemical effects of the drugs.
Introduction
aptic populations affected by the drugs. 7 In a similar vein, we studied the effects of 2 weeks' haloperidol Repeated administration of antipsychotic drugs protreatment in the rat, and found that synaptophysin duces a variety of neurochemical and ultrastructural expression was increased in dorsolateral striatum, 8 effects in the striatum and in some other brain with a trend in frontoparietal cortex 8 but no change in regions. [1] [2] [3] How the pharmacological and morphologihippocampus. 9 Synaptophysin, a presynaptic terminal cal effects are related is unresolved, as is the contriprotein, is an established marker of synapses 10,11 and bution which each makes to the long-term therapeutic has been used to demonstrate synaptic alterations in and side-effect profile of antipsychotics. One way in pathological 9,12,13 and experimental 14-18 conditions. As which these fields can be integrated is by studying the such, we interpreted the increased synaptophysin expression of genes involved in neural activation and expression in haloperidol-treated rats as evidence for plasticity, processes by which the effects of a drug on an increased density or a reorganisation of striatal synneuroreceptors may be transduced into chronic and aptic populations, in agreement with earlier electron structural sequelae. 4 For example, brain regions differmicroscopy data. [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] entially activated by typical and atypical antipsyMost studies of antipsychotic drug effects on gene chotics have been identified using oncogene expression expression have been limited to acute or subchronic as a marker, 5, 6 and mRNAs encoding vesicle-associated treatment. Longer-term studies are also necessary since proteins have been used to localise neuronal and synprolonged or late-onset changes in gene expression may contribute to the delayed therapeutic benefits and side-effects of antipsychotics. In the present study, we ation histochemistry (ISHH) analysis of synaptophysin mRNA, which was carried out both regionally and 'per ISHH conditions were as described. 8, 42 Two probes targetting rat GAP-43 mRNA 43 were used: 5′-cell'; in addition we used immunoautoradiography to see if synaptophysin itself was altered by haloperidol TGCGCTTGTTTAGGCTCCTCCTTGGCTGGG-3′ (bases 519-548), and 5′-ACTCCCACAGGGCCACACGCACCAtreatment.
Two other mRNAs were measured to aid in the GATCAA-3′ (bases 1041-1070). The cyclophilin probe sequence was 5′-ACCAGTGCCATTATGGCGTGTGAinterpretation of changes in synaptophysin expression which might be observed. Firstly, we assessed the tran-AGTCACCACCCTG-3′, complementary to bases 229-264 of the rat cDNA. 44 GAP-43 ISHH was carried out script encoding growth-associated protein-43 (GAP-43; also called B-50, F1 or neuromodulin). GAP-43 is a with incubation at 31°C and post-hybridization washes at 56°C in 0.5 × SSC. Cyclophilin ISHH incubation was well characterised and widely used molecular indicator of neurons undergoing plasticity and structural performed at 35°C with post-hybridization washes at 55°C in 1 × SSC. 45 Exposure times were 25 days remodelling. 29, 30 Its expression is regulated developmentally, [31] [32] [33] is elevated following a variety of experi-(synaptophysin mRNA), 14 days (GAP-43 mRNA) and 26 days (cyclophilin mRNA), against Hyperfilm betamental manipulations, [34] [35] [36] [37] and is decreased in neurons affected by neuropathological processes. [38] [39] [40] Thus, max (Amersham, Little Chalfont, UK) together with 14 C standards (Amersham). The striatal sections used for increased GAP-43 mRNA in haloperidol-treated animals would suggest that the drug enhances neuronal synaptophysin ISHH were subsequently dipped in emulsion (LM1, Amersham), stored at 4°C for 6 weeks plasticity more generally than the synaptic plasticity inferred by the synaptophysin data. Cyclophilin then developed and lightly counterstained with cresyl violet. mRNA, a housekeeping gene transcript, was also measured because a change in its abundance would imply A range of experimental controls for ISHH were used: (1) ribonuclease pretreatment of sections; a non-specific effect on haloperidol on overall mRNA content and gene expression. In order to build up a (2) hybridization with sense probes; (3) northern analysis; (4) use of the two probes directed against diftemporal profile of their responses to haloperidol, GAP-43 and cyclophilin mRNAs were also measured ferent parts of GAP-43 mRNA; and (5) hybridization in the presence of 50-fold excess cold antisense oligoin the 2-week treatment group used for the initial synaptophysin study.
nucleotide. Immunoautoradiography was carried out using a Overall, therefore, the experiments addressed two main questions: does haloperidol, a prototypical antimonoclonal anti-synaptophysin primary antibody conjugated to a 35 S-labelled secondary antibody, as descripsychotic, produce sustained effects on synapses, as evinced by increased synaptophysin expression after bed.
46
The areas of interest for ISHH analysis comprised: its chronic administration? Does the same treatment have more widespread effects on neuronal plasticity, striatum (dorsolateral quadrant), frontoparietal cortex, and hippocampus (dentate gyrus, CA3 and CA1). Synas indexed by GAP-43 expression? The results were intended to help elucidate molecular pathways by aptophysin immunoautoradiographic data were analysed in dorsolateral striatum and frontoparietal cortex. which the initial consequences of receptor occupancy by antipsychotic drugs are related to their long-term For image analysis of films, each area of interest was outlined on the monitor, blind to treatment status, and morphological effects.
calibrated to the 14 C standards, with values converted to 35 S equivalents. 47 For the cellular analysis, grain Materials and methods density was measured under dark field illumination over 30-50 large neurons in the dorsolateral striatum, Adult male Sprague-Dawley rats weighing 220 ± 17 g (mean ± s.d.) were maintained on a 12-h light/dark and over 30-50 pyramidal neurons in lamina V/VI and in lamina II/III of the overlying cortex of each animal. , by i.m. For data analysis, measurements were averaged from the three adjacent sections hybridized per probe. Statinjection every 3 weeks, or were injected with the same volume of sesame oil vehicle (n = 7 in each group). The istical analysis was carried out using one-and two-way ANOVA, with significance set at P = 0.05. haloperidol dose is similar to that used in earlier studies. 26, 41 One week after the fifth injection (ie after 16 weeks), animals were killed by decapitation. Weights Results at death in both groups were identical (haloperidoltreated: 400 ± 42 g; vehicle controls: 401 ± 21 g). Brains
The distribution of synaptophysin mRNA ( Figure 1a ) was as reported, 8 being prominent throughout the corwere frozen in embedding compound on a dry ice/alcohol slurry and stored at −70°C. Twelvetex, especially in lamina VI, and with a punctate signal in dorsolateral striatum which on dipped sections is micrometre cryostat sections were cut at the level of the mid-striatum and dorsal hippocampus and seen to arise from large, putatively cholinergic, interneurons. 8, 48 GAP-43 mRNA also showed the predicted mounted three per slide. The 2-week treatment group received haloperidol, 2 mg kg −1 day −1 by intraperiexpression pattern ( Figure 1c ). For example, it was present at only minimal levels in the dentate gyrus 49- toneal injection. S-3Ј-labelled oligonucleotide probes were used for 51 (data not shown). In dorsolateral striatum, a relatively weak signal was observed which, like synaptodetection of each mRNA. The synaptophysin probe and physin mRNA, was punctate and reflects expression synaptophysin antibody led to minimal background signal. primarily in cholinergic interneurons. 52, 53 In the frontal cortex, there was a prominent band of GAP-43 mRNA- Table 1 summarises the regional abundance of the three mRNAs in each brain area examined in the 16-labelled neurons in lamina II/III and one in lamina VI. 50, 51 Cyclophilin mRNA was ubiquitously expressed week treatment and control groups. Film autoradiographic signal for synaptophysin mRNA was increased at moderate levels 45 (data not shown). Specificity of all hybridization signals was confirmed by the experiby haloperidol treatment (P Ͻ 0.0001) with significant increases in dorsolateral striatum (P Ͻ 0.01) and fronmental controls used: no significant labelling was observed after ribonuclease treatment, sense strand toparietal cortex (P Ͻ 0.05) of the haloperidol-treated rats (illustrated in Figure 1a and b). Neither GAP-43 hybridization, or excess cold probe; northern analysis of rat brain total RNA hybridized with the 32 P-3′-labmRNA (illustrated in Figure 1c and d) nor cyclophilin mRNA were significantly affected by haloperidol treatelled GAP-43 oligonucleotides showed a single band of the anticipated molecular weight (1.6 kb, 31, 43 ; not ment in any area. Because of the regional increases in synaptophysin shown). Identical ISHH signal distribution was obtained with both GAP-43 probes, but the images mRNA, we then quantified its abundance in individual neuron populations within the striatum and cortex. were stronger with the first oligonucleotide listed above, which was used for the quantitative ISHH stud-
The cellular level of resolution overcomes the possibility that the film autoradiographic data are conies. Immunoautoradiography after omission of the anti- No significant GAP-43 mRNA signal in dentate gyrus. *P Ͻ 0.05, **P Ͻ 0.01, one-way ANOVA.
founded by an effect of haloperidol on neuronal densynaptophysin mRNA corresponds to synaptophysin transported to synapses in regions not measured in the sity.
54-57
The cellular analysis showed that synaptophysin expression is increased in large striatal study (see Discussion). Figure 2 summarises the relative changes in the gene neurons and in cortical pyramidal neurons in chronic haloperidol-treated animals ( Table 2) .
products in the dorsolateral striatum and frontoparietal Table 3 indicates that the increase in synaptophysin mRNA in the haloperidol-treated animals is accompanied by an increased expression of synaptophysin, assessed immunoautoradiographically. However, the latter results did not reach significance, due to a larger variance and a smaller sample size because sections from three animals were unavailable. It may also be that some of the increased striatal and cortical Overall effect of treatment, F 1,42 = 30.1, P Ͻ 0.0001. *P Ͻ 0.025, **P = 0.01, ***P Ͻ 0.001, one-way ANOVA. cortex of the 2-and 16-week treatment groups comwhereas the encoded protein is detected in synaptic terminals, some of which will be in other cytoarchitecpared to their respective controls. In striatum, synaptophysin mRNA is increased at both time points, whereas tonic fields or brain regions. 8, 65 For example, synaptophysin mRNA was increased in pyramidal neurons of synaptophysin increases only after the longer treatment. Striatal GAP-43 expression does not change in both middle and deep laminae in the frontoparietal cortex (Table 2 ). Many deep cortical pyramidal neuresponse to either haloperidol treatment duration. A somewhat different pattern of results is seen in the corrons project to the striatum, so the elevated synaptophysin mRNA in these cells contributes to the tex: GAP-43 mRNA is elevated in the 2-week treatment group, with a lesser and non-significant increase after enhanced synaptophysin signal in the striatum of haloperidol-treated animals (Table 3 and Figure 2 ). On the 16 weeks' haloperidol, whereas synaptophysin expression shows the opposite profile. Cyclophilin other hand, lamina II/III cortical pyramidal neurons do not project to the striatum; increased synaptophysin mRNA was unaffected by haloperidol in either area at either timepoint, excluding a non-specific effect of the mRNA in these neurons indicates that cortical synaptic plasticity associated with chronic haloperidol is not drug upon mRNA expression.
restricted to neurons with their terminals in the striatum. For two complementary reasons, the anatomical Discussion divergence between mRNA and protein distribution may also partially explain the fact that the haloperidolAlterations in the number, structure or organisation of synapses are an important consequence of antipsyinduced elevation of synaptophysin in the striatum was of smaller magitude than that of the encoding chotic drug administration, mainly in dorsolateral striatum 19-28 but also in frontal cortex [57] [58] [59] and in some mRNA (Tables 1-3) . Firstly, some of the synapses formed by cortical and striatal neurons are situated elseother regions (see Ref.
3). Previously, we found that the mRNA encoding synaptophysin, a major presynaptic where and will not contribute to the synaptophysin immunoautoradiographic signal in the cortex or striavesicle protein, is increased in dorsolateral striatum of rats treated for 2 weeks with haloperidol. 8 The present tum. Secondly, a proportion of synaptophysin in the striatum and cortex will be in the terminals of neurons findings show that synaptophysin expression remains elevated in the dorsolateral striatum after chronic halowhose perikarya are located in other brain regions and in which synaptophysin expression might be peridol treament (Tables 1-3 and Figure 1) ; the ISHH signal was increased by 40%, whilst the immunoautounchanged or decreased by haloperidol. Therefore in order to produce a complete picture of the neuronal radiographic signal was increased by 20% (Figure 2 ). These alterations in synaptophysin expression are and synaptic populations in which synaptophysin expression is affected by haloperidol treatment, it will likely to be biologically significant, since changes of a similar magnitude occur in Alzheimer's disease 12, 13 be necessary to carry out detailed studies of multiple brain areas, using combined cellular ISHH and immunand after experimental manipulations 16 where they have demonstrable functional correlates. We conclude ocytochemical or immunoautoradiographic measurements. Nevertheless, it is already clear from the hippothat the enhanced synaptophysin expression seen in the present study is a component of, and provides campal synaptophysin mRNA data (Table 1) , and from earlier studies, 9, 23 that increased synaptophysin further evidence for, synaptic sprouting or remodelling occurring in response to antipsychotic treatment. Simiexpression induced by haloperidol is not of uniform magnitude or occurrence throughout the brain. lar processes may contribute to the caudate enlargement [60] [61] [62] and striatal neuropathology 63, 64 which are Synaptophysin expression is usually considered to reflect synaptic density, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] and in this respect our data observed in patients treated long-term with these drugs.
are consistent with the finding that striatal synaptic density is increased in animals treated for 24 days with Within the striatum, our data show that large cholinergic interneurons express more synaptophysin 1.25 mg kg −1 day −1 haloperidol. 24 However, another electron microscopy study found no increase in synapmRNA after administration of haloperidol (Table 2) . However, we cannot determine if other striatal neuron tic density in the striatum of rats treated for 6 months with ෂ1.5 mg kg −1 day −1 haloperidol; indeed there were populations show a similar change, since their smaller size and lower level of synaptophysin expression make minor decreases in some animals. 27 The different durations and dosages of treatment in these studies may cellular quantitation problematic. Hence we have not speculated upon the significance which synaptic plasexplain the divergence of results. On the other hand, given the negative results of Roberts et al (1995) 27 and ticity, were it to be limited to cholinergic neurons, might have for striatal function following haloperidol the status of electron microscopy as the 'gold standard' for measuring synaptic density, on this occasion it is treatment.
Synaptophysin mRNA was also increased in the possible that elevated synaptophysin expression is not reflecting increased synaptic density. Instead, it may frontoparietal cortex (Table 1 and Figure 2) , consistent with ultrastructural evidence for cortical synaptic be indicative of other synaptic alterations requiring enhanced synaptophysin synthesis, such as more vesalterations after haloperidol. [57] [58] [59] However, consideration of the cellular ISHH data leads to more complex icles per synapse, a change in the proportions of synaptic types, or other changes in the ultrastructure of syninterpretations, bearing in mind that ISHH identifies the cell bodies of neurons expressing synaptophysin, aptic terminal populations. treated animals will also inform the parallel investi- 
